Shanxi Zhendong Pharmaceutical Co.,Ltd (SHE:300158)
China flag China · Delayed Price · Currency is CNY
5.74
+0.02 (0.35%)
Apr 29, 2026, 3:04 PM CST

SHE:300158 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Cash & Equivalents
249.2511.9584.59800.88720.271,222
Short-Term Investments
--5.01---
Trading Asset Securities
533.69489.97989.621,4482,0194,470
Cash & Short-Term Investments
782.891,0021,5792,2492,7405,692
Cash Growth
-33.34%-36.56%-29.78%-17.91%-51.87%508.77%
Accounts Receivable
890.05890718.07856.04809.3945.55
Other Receivables
102.8854.957.7544.7157.44502.55
Receivables
992.93944.9775.81900.75866.741,448
Inventory
654.12649.91775.981,1951,074937.14
Prepaid Expenses
--6.114.180.912.52
Other Current Assets
67.9271.5278.49111.08201.62344.11
Total Current Assets
2,4982,6683,2164,4604,8838,424
Property, Plant & Equipment
1,1031,1071,046994.91,0101,047
Long-Term Investments
78.7878.7338.6557.0258.3458.3
Goodwill
15.515.515.540.2440.2440.24
Other Intangible Assets
326.03331.46288.85260.07258.39250.37
Long-Term Accounts Receivable
----0.121.11
Long-Term Deferred Tax Assets
24.7228.1324.9721.0118.8723.83
Long-Term Deferred Charges
140.84135.97101.37200.37201.06195.49
Other Long-Term Assets
286.39257.58251.29146.680.4153.21
Total Assets
4,4734,6224,9836,1806,55110,093
Accounts Payable
317.47345.29328.01418504.48584.92
Accrued Expenses
29.633.13229.55251.35289.2410.52
Short-Term Debt
196.42176.9638.110.120.48210.77
Current Portion of Long-Term Debt
-1.53----
Current Portion of Leases
--2.011.220.310.73
Current Income Taxes Payable
32.4410.65--9.33422.7
Current Unearned Revenue
46.6153.9351.4268.42147.5986.59
Other Current Liabilities
454.74648.52605.94177.98237.9383.86
Total Current Liabilities
1,0771,2701,255917.071,2091,800
Long-Term Debt
45.9-0.180.18-100.14
Long-Term Leases
5.876.151.091.531.081.08
Long-Term Unearned Revenue
35.335.2937.6542.7742.4956.38
Long-Term Deferred Tax Liabilities
0.471.120.980.3--
Other Long-Term Liabilities
--27.5474.5474.7281.3
Total Liabilities
1,1651,3131,3221,0361,3282,039
Common Stock
992.3992.31,0051,0271,0271,027
Additional Paid-In Capital
3,6433,6433,6823,7623,7623,762
Retained Earnings
-1,209-1,208-906.81421.76465.743,291
Treasury Stock
---2.84---
Comprehensive Income & Other
-78.67-78.68-79.78-32.71-1.39-1.47
Total Common Equity
3,3483,3493,6985,1795,2548,080
Minority Interest
-39.54-39.4-37.37-34.75-30.86-25.15
Shareholders' Equity
3,3083,3103,6605,1445,2238,054
Total Liabilities & Equity
4,4734,6224,9836,1806,55110,093
Total Debt
248.19184.6341.393.0321.87312.72
Net Cash (Debt)
534.7817.231,5382,2462,7185,379
Net Cash Growth
-53.81%-46.86%-31.52%-17.36%-49.48%1003.25%
Net Cash Per Share
0.530.811.502.192.645.24
Filing Date Shares Outstanding
950.821,0071,0241,0271,0271,027
Total Common Shares Outstanding
950.821,0071,0241,0271,0271,027
Working Capital
1,4211,3981,9613,5433,6746,623
Book Value Per Share
3.523.323.615.045.117.86
Tangible Book Value
3,0063,0023,3934,8794,9567,789
Tangible Book Value Per Share
3.162.983.314.754.827.58
Buildings
--1,1671,1441,0941,033
Machinery
--864.1832.12824.63783.61
Construction In Progress
--119.444.9824.2119.89
Source: S&P Global Market Intelligence. Standard template. Financial Sources.